534 related articles for article (PubMed ID: 9762378)
1. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
Cerveny JD; Leder RD; Weart CW
Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
[TBL] [Abstract][Full Text] [Related]
2. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
3. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
[TBL] [Abstract][Full Text] [Related]
4. New strategies for basal insulin treatment in type 2 diabetes mellitus.
Dailey G
Clin Ther; 2004 Jun; 26(6):889-901. PubMed ID: 15262459
[TBL] [Abstract][Full Text] [Related]
5. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
6. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.
Shogbon AO; Levy SB
Am J Health Syst Pharm; 2010 May; 67(10):798-805. PubMed ID: 20479101
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri M; Kishikawa H; Ohkubo Y; Wake N
Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
[TBL] [Abstract][Full Text] [Related]
8. The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes.
Stern MP
Arch Fam Med; 1998; 7(2):155-62. PubMed ID: 9519921
[TBL] [Abstract][Full Text] [Related]
9. New frontiers in the management of type 2 diabetes.
Mudaliar S
Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
[TBL] [Abstract][Full Text] [Related]
10. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results.
Colwell JA
Diabetes; 1996 Jul; 45 Suppl 3():S87-90. PubMed ID: 8674902
[TBL] [Abstract][Full Text] [Related]
11. Importance of glucose control.
Edelman SV
Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
[TBL] [Abstract][Full Text] [Related]
12. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
[TBL] [Abstract][Full Text] [Related]
13. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus in older patients. Is tight blood glucose control warranted?
Lunt H
Drugs Aging; 1996 Jun; 8(6):401-7. PubMed ID: 8736623
[TBL] [Abstract][Full Text] [Related]
15. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
Ma J; Yang W; Fang N; Zhu W; Wei M
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes among women: clinical considerations for pharmacological management to achieve glycemic control and reduce cardiovascular risk.
Levine JP
J Womens Health (Larchmt); 2008 Mar; 17(2):249-60. PubMed ID: 18321176
[TBL] [Abstract][Full Text] [Related]
17. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association.
Woolf SH; Davidson MB; Greenfield S; Bell HS; Ganiats TG; Hagen MD; Palda VA; Rizza RA; Spann SJ
J Fam Pract; 2000 May; 49(5):453-60. PubMed ID: 10836779
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinedione therapy: the benefits of aggressive and early use in type 2 diabetes.
Reusch JE; Gadsby R
Diabetes Technol Ther; 2003; 5(4):685-93. PubMed ID: 14511423
[TBL] [Abstract][Full Text] [Related]
19. Gycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus.
Palumbo PJ
Mayo Clin Proc; 2001 Jun; 76(6):609-18. PubMed ID: 11393500
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes.
Kunutsor SK; Balasubramanian VG; Zaccardi F; Gillies CL; Aroda VR; Seidu S; Khunti K
Diabetes Obes Metab; 2024 Jun; 26(6):2069-2081. PubMed ID: 38409644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
